NCT07417930 Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation
| NCT ID | NCT07417930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Klein Buendel, Inc. |
| Condition | Parenting |
| Study Type | INTERVENTIONAL |
| Enrollment | 516 participants |
| Start Date | 2026-07-27 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 516 participants in total. It began in 2026-07-27 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the effects of the hybrid ezParent program (e.g., web-based training program plus synchronous group sessions) on parent and child outcomes in a community setting serving parents of children 2-5 years old. Parent participants will complete surveys at baseline, and 10 and 24-weeks post baseline.
Eligibility Criteria
Inclusion Criteria: * Parent or legal guardian of a 2-5-year-old child receiving services at the partnering organization site. * Speaks English or Spanish. * Has a smartphone, tablet, or computer with Wi-Fi access to receive the ezParent program. Exclusion Criteria: • Parents who have previously participated in CPP or ezParent will be excluded.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07417930 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parenting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07417930 currently recruiting?
Yes, NCT07417930 is actively recruiting participants. Contact the research team at breitenstein.5@osu.edu for enrollment information.
Where is the NCT07417930 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT07417930 clinical trial?
NCT07417930 is sponsored by Klein Buendel, Inc.. The trial plans to enroll 516 participants.